Researcher
Cédric Draulans
- Disciplines:Cancer therapy
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Aug 2016 → Today
Projects
1 - 1 of 1
- The Treasury of Images: exploring the opportunities for diagnosing and treating prostate cancerFrom1 Aug 2016 → 23 Nov 2020Funding: Private funding of national origin - undefined
Publications
21 - 30 of 33
- Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a populationbased cohort study(2020)
Authors: Cédric Draulans, Sofie Isebaert, Wouter Everaerts, Gert De Meerleer, Karin Haustermans
Pages: 904 - 910 - Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer(2020)
Authors: Cédric Draulans, Karin Haustermans, Robin De Roover, Tom Depuydt, Sofie Isebaert
Pages: 92 - 98 - Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection(2020)
Authors: Cédric Draulans, Wouter Everaerts, Sofie Isebaert, Thomas Gevaert, Raymond Oyen, Steven Joniau, Annouschka Laenen, Birgit Weynand, Gilles Defraene, Gert De Meerleer, et al.
Pages: 713 - 718 - Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus(2019)
Authors: Cédric Draulans, Robin De Roover, Karin Haustermans, Tom Depuydt, Sofie Isebaert
Pages: 131 - 142 - Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification(2019)
Authors: Cédric Draulans, Wouter Everaerts, Sofie Isebaert, Thomas Gevaert, Raymond Oyen, Steven Joniau, Birgit Weynand, Gert De Meerleer, Karin Haustermans
Pages: 113 - 119 - Impact of MRI on prostate cancer risk classification: game changer for therapeutic decision making?(2019)
Authors: Cédric Draulans, W Everaerts, S Isebaert, G Thomas, R Oyen, S Joniau, E Lerut, L De Wever, B Weynand, E Vanhoutte, et al.
Pages: S838 - S838 - When PI-RADS and ISUP meet each other: identification of candidates for pelvic lymph node dissection(2019)
Authors: Cédric Draulans, W Everaerts, S Isebaert, T Gevaert, R Oyen, S Joniau, E Lerut, L De Wever, A Laenen, B Weynand, et al.
Pages: S77 - S78 - Focal boost dose escalated prostate SBRT on the Halcyon fast-rotating O-ring linac(2019)
Authors: R De Roover, Wouter Crijns, S Michiels, Cédric Draulans, K Poels, K Haustermans, T Depuydt
Pages: S499 - S499 - Treatment plan quality assessment for focal dose escalation in prostate cancer(2019)
Authors: M Van Schie, T Janssen, D Eekhout, I Walraven, A Kotte, L Kerkmeijer, Cédric Draulans, K Haustermans, RJ Smeenk, U Van der Heide
Pages: S498 - S498 - Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial(2018)
Authors: Cédric Draulans, Steven Joniau, Wouter Everaerts, Wouter Crijns, Karin Haustermans, Charlien Berghen, Gert De Meerleer